Genetic Profile and Treatment of NSCLC
We recommend
Complete remission of ALK-positive lung cancer in a patient after multiple lines of targeted therapy – a case study
Targeted treatment for driving oncogenic mutations has significantly improved outcomes for patients with ALK-positive non-small cell lung cancer (NSCLC) as well. A case study was recently published in the journal Frontiers in Oncology of a patient with advanced disease who achieved complete remission after several lines of therapy.
Lorlatinib in a Patient with Meningeal Carcinomatosis – Case Report
The prognosis of patients with meningeal carcinomatosis is unfavorable. The following case report…
Lorlatinib as an Alternative to CNS Radiotherapy in Patients with NSCLC − Case Studies
Two remarkable case studies from authors at the Netherlands Cancer Institute Antoni van Leeuwenhoek…
Subscribe
Most read on this topic
Journal on this topic
Related topic
Most read on this topic
- Lorlatinib in a Patient with Meningeal Carcinomatosis – Case Report
- Complete remission of ALK-positive lung cancer in a patient after multiple lines of targeted therapy – a case study
- Lorlatinib as an Alternative to CNS Radiotherapy in Patients with NSCLC − Case Studies
Journal on this topic
Related topic